Emerging Therapies for Age-Related Macular Degeneration
Date: 28/03/2022 (AEDT)
Venue: 33 Bultje Street, Dubbo, NSW, 2830
Provider: INSERVIO PTY LTD
Contact: INSERVIO PTY LTD, [E] Tina.Xenoulis@inservio.com.au, [P] 0432808708
Learning Objectives
- Understand the “gold standard” treatment for neovascular AMD
- Understand serious complication of intravitreal agents for neovascular AMD
- Understand new and potential treatments for non-neovascular AMD
Max CPD hours awarded: 1.25
Session Information
Name |
---|
Emerging therapies for Age-Related Macular Degeneration |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
Yes |
Duration of CPD Session/Module |
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
1.25 |